Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 4;13(11):3321.
doi: 10.3390/jcm13113321.

Impact of Cognitive Impairment on Quality of Life in Multiple Sclerosis Patients-A Comprehensive Review

Affiliations
Review

Impact of Cognitive Impairment on Quality of Life in Multiple Sclerosis Patients-A Comprehensive Review

Sara Gómez-Melero et al. J Clin Med. .

Abstract

Multiple sclerosis (MS) is characterized by a variety of symptoms that have a major impact on quality of life (QoL) even in early stages. In addition to individual motor, sensory, visual disturbances, and brainstem and sphincter disorders, which are expressed through the widely used Expanded Disability Status Scale (EDSS), other manifestations of MS have a detrimental effect on overall functioning and quality of life, such as cognitive impairment, depression, anxiety, fatigue, and pain. However, when talking about QoL, categorical definitions cannot be used because although the concept is generally understood, it is highly nuanced. Suffering from MS can significantly reduce QoL. Numerous research studies have focused on trying to identify and assess which are the elements that most affect the loss of QoL in MS people. However, in addition to the fact that the measurement of QoL can be subjective, it is very difficult to consider these elements in isolation, as they are interrelated. One such limiting factor of QoL that has been investigated is cognitive impairment (CI). This has been shown to have an impact on the lives of MS people, although the different approaches that have been taken to assess CI have evident limitations.

Keywords: cognitive impairment; disability; multiple sclerosis; neurodegenerative diseases; quality of life.

PubMed Disclaimer

Conflict of interest statement

This study has no sponsors or incentives, nor did it require funding for its development. Neither the participating investigators nor the hospital center have received any financial compensation. The authors declare that they have no conflicts of interest.

Similar articles

Cited by

References

    1. Jakimovski D., Bittner S., Zivadinov R., Morrow S.A., Benedict R.H., Zipp F., Weinstock-Guttman B. Multiple sclerosis. Lancet. 2024;403:183–202. doi: 10.1016/S0140-6736(23)01473-3. - DOI - PubMed
    1. Walton C., King R., Rechtman L., Kaye W., Leray E., Marrie R.A., Robertson N., La Rocca N., Uitdehaag B., Van Der Mei I., et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult. Scler. 2020;26:1816–1821. doi: 10.1177/1352458520970841. - DOI - PMC - PubMed
    1. Logroscino G., Piccininni M., Marin B., Nichols E., Abd-Allah F., Abdelalim A., Alahdab F., Asgedom S.W., Awasthi A., Chaiah Y., et al. Global, regional, and national burden of motor neuron diseases 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:1083–1097. doi: 10.1016/S1474-4422(18)30404-6. - DOI - PMC - PubMed
    1. Koch-Henriksen N., Magyari M. Apparent changes in the epidemiology and severity of multiple sclerosis. Nat. Rev. Neurol. 2021;17:676–688. doi: 10.1038/S41582-021-00556-Y. - DOI - PubMed
    1. Ghasemi N., Razavi S., Nikzad E. Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses andCell-Based Therapy. Cell J. 2017;19:1. doi: 10.22074/CELLJ.2016.4867. - DOI - PMC - PubMed

LinkOut - more resources